Duke, Bristol-Myers Squibb Open Up Study Data

Duke University, through its Duke Clinical Research Institute (DCRI), has entered into a collaboration with Bristol-Myers Squibb (BMS) to promote open access to clinical information from company-sponsored studies.

The purpose of the collaboration is to support BMS’s efforts at expanded transparency and leverage existing resources for scientific discovery and improve public health, according to the company. BMS’s efforts will increase access to a broader set of clinical trial information from in-scope, company-sponsored studies and enable independent scientific review through DCRI of requests from researchers that meet pre-specified requirements. The DCRI will also review the final manuscripts produced from the data for scientific integrity and consistency with the original proposed work.

Get access to this article and thousands more...

All Health Data Management articles are archived after 7 days. REGISTER NOW for unlimited access to all recently archived articles, as well as thousands of searchable stories. Registered Members also gain access to exclusive industry white paper downloads, web seminars, podcasts, e-books, and conference discounts. Qualified members may also choose to receive our free monthly magazine and any of our e-newsletters covering the latest breaking news, opinions from industry leaders, developing trends and specialized topics like EHR's, revenue cycle management, health insurance exchanges, analytics, and more!

Already Registered?

Forgot Password/Need Help?
Comments (0)

Be the first to comment on this post using the section below.

Add Your Comments:
Not Registered?
You must be registered to post a comment. Click here to register.
Already registered? Log in here
Please note you must now log in with your email address and password.


Slide Shows

Already a subscriber? Log in here
Please note you must now log in with your email address and password.